News & Events

Event

Jan 28 - Feb 01, 2018

Progress and Pathways Toward an Effective HIV Vaccine

After three decades, HIV-1 continues to afflict and kill millions of people worldwide. A safe and effective vaccine that elicits potent and durable protective immunity has the greatest prospect to end the AIDS epidemic. Development of an HIV vaccine has proven scientifically challenging. However, the field is in a phase of rapid growth and innovation for new vaccine strategies that hold promise for efficacy.

AIDS Research and Human Retroviruses was the very first AIDS publication in the field over 30 years ago, and today it is still the critical resource advancing research in retroviruses, including AIDS.

The Journal provides the broadest coverage from molecular biology to clinical studies and outcomes research, focusing on developments in prevention science, novel therapeutics, and immune-restorative approaches. Cutting-edge papers on the latest progress and research advances through clinical trials and examination of targeted antiretroviral agents lead to improvements in translational medicine for optimal treatment outcomes.

Pick up your copy of this essential resource at Progress and Pathways Toward an Effective HIV Vaccine.